Cargando…

Gypenoside L and Gypenoside LI Inhibit Proliferation in Renal Cell Carcinoma via Regulation of the MAPK and Arachidonic Acid Metabolism Pathways

Renal cell carcinoma (RCC) has the highest mortality rate of all urological malignancies. Clear cell renal cell carcinoma (ccRCC) accounts for approximately 80% of all RCC cases and is often accompanied by the accumulation of lipid droplets. Growing evidence indicates that ccRCC is a metabolism-rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hui, Li, Xiuming, Xie, Jinbo, Lv, Chengcheng, Lian, Fangchao, Zhang, Shouyi, Duan, Yu, Zeng, Yu, Piao, Xianglan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964777/ https://www.ncbi.nlm.nih.gov/pubmed/35370678 http://dx.doi.org/10.3389/fphar.2022.820639

Ejemplares similares

Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer
por: Li, Xiuming, et al.
Publicado: (2022)

Gypenosides ameliorate ductular reaction and liver fibrosis via inhibition of hedgehog signaling
por: Hu, Yonghong, et al.
Publicado: (2022)

Determination of Gypenoside A and Gypenoside XLIX in Rat Plasma by UPLC-MS/MS and Applied to the Pharmacokinetics and Bioavailability
por: He, Yan, et al.
Publicado: (2022)

Comprehensive serum metabolomics and network analysis to reveal the mechanism of gypenosides in treating lung cancer and enhancing the pharmacological effects of cisplatin
por: Qi, Yan-Shuang, et al.
Publicado: (2022)

Gypenosides Attenuate Pulmonary Fibrosis by Inhibiting the AKT/mTOR/c-Myc Pathway
por: Liu, Suqing, et al.
Publicado: (2022)

Natural gypenosides: targeting cancer through different molecular pathways
por: Ahmad, Bashir, et al.
Publicado: (2019)

Hypolipidemic effect of gypenosides in experimentally induced hypercholesterolemic rats
por: Yang, Yue-Hui, et al.
Publicado: (2013)

Gypenoside L Inhibits Proliferation of Liver and Esophageal Cancer Cells by Inducing Senescence
por: Ma, Jingxin, et al.
Publicado: (2019)

Multi‑omics‑based analysis of the regulatory mechanism of gypenosides on bile acids in hypercholesterolemic mice
por: Feng, Chengcheng, et al.
Publicado: (2023)

Gypenosides Attenuate Lipopolysaccharide-Induced Neuroinflammation and Memory Impairment in Rats
por: Lee, Bombi, et al.
Publicado: (2018)

Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
por: Lee, Jin Ha, et al.
Publicado: (2020)

Gypenosides Alleviate Cone Cell Death in a Zebrafish Model of Retinitis Pigmentosa
por: Li, Xing, et al.
Publicado: (2021)

Ameliorating effects of gypenosides on chronic stress-induced anxiety disorders in mice
por: Zhao, Ting Ting, et al.
Publicado: (2015)

Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and anxiety-like behaviors in rats
por: Lee, Bombi, et al.
Publicado: (2018)

Gypenoside Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of Mitogen-Activated Protein Kinase Mediated Nuclear Factor Kappa B Pathway In Vitro and In Vivo
por: Yu, Haijie, et al.
Publicado: (2016)

Biotransformation of ginsenoside Rb1 via the gypenoside pathway by human gut bacteria
por: Shen, Hong, et al.
Publicado: (2013)

Hybrid sequencing of the Gynostemma pentaphyllum transcriptome provides new insights into gypenoside biosynthesis
por: Liang, Tongtong, et al.
Publicado: (2019)

Chromosome-level genome assembly of Gynostemma pentaphyllum provides insights into gypenoside biosynthesis
por: Huang, Ding, et al.
Publicado: (2021)

Gypenosides Prevent and Dissolve Cholesterol Gallstones by Modulating the Homeostasis of Cholesterol and Bile Acids
por: Zhuang, Qian, et al.
Publicado: (2022)

Therapeutic Effect of Gypenosides on Antioxidant Stress Injury in Orbital Fibroblasts of Graves' Orbitopathy
por: Ma, Chao, et al.
Publicado: (2022)

Chemical composition of tetraploid Gynostemma pentaphyllum gypenosides and their suppression on inflammatory response by NF‐κB/MAPKs/AP‐1 signaling pathways
por: Wang, Bo, et al.
Publicado: (2020)

Gypenosides Synergistically Reduce the Extracellular Matrix of Hepatic Stellate Cells and Ameliorate Hepatic Fibrosis in Mice
por: Li, Han, et al.
Publicado: (2023)

Mechanistic Studies of Gypenosides in Microglial State Transition and its Implications in Depression-Like Behaviors: Role of TLR4/MyD88/NF-κB Signaling
por: Cao, Li-Hua, et al.
Publicado: (2022)

Enzymatic Biotransformation of Gypenoside XLIX into Gylongiposide I and Their Antiviral Roles against Enterovirus 71 In Vitro
por: Zhao, Huanxi, et al.
Publicado: (2022)

Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data
por: Song, Ya-Nan, et al.
Publicado: (2017)

Gypenosides Altered Hepatic Bile Acids Homeostasis in Mice Treated with High Fat Diet
por: Lu, Yanliu, et al.
Publicado: (2018)

Gypenosides improve diabetic cardiomyopathy by inhibiting ROS‐mediated NLRP3 inflammasome activation
por: Zhang, Hailong, et al.
Publicado: (2018)

The components data of fuzheng huayu extracts, cordyceps sinensis mycelia polysaccharide, gypenosides and amygdalin
por: Liu, Wei, et al.
Publicado: (2019)

Research on the Potential Mechanism of Gypenosides on Treating Thyroid-Associated Ophthalmopathy Based on Network Pharmacology
por: Li, Kaijun, et al.
Publicado: (2019)

Gypenosides Protected the Neural Stem Cells in the Subventricular Zone of Neonatal Rats that Were Prenatally Exposed to Ethanol
por: Dong, Lun, et al.
Publicado: (2014)

Gypenosides induce cell death and alter gene expression in human oral cancer HSC-3 cells
por: Lu, Kung-Wen, et al.
Publicado: (2017)

Anti-Cancer Effect and the Underlying Mechanisms of Gypenosides on Human Colorectal Cancer SW-480 Cells
por: Yan, Han, et al.
Publicado: (2014)

Induction of p53-independent growth inhibition in lung carcinoma cell A549 by gypenosides
por: Liu, Jung-Sen, et al.
Publicado: (2015)

Gypenosides Protect Orbital Fibroblasts in Graves Ophthalmopathy via Anti-Inflammation and Anti-Fibrosis Effects
por: Li, Haoyu, et al.
Publicado: (2020)

Production of Gypenoside XVII from Ginsenoside Rb1 by Enzymatic Transformation and Their Anti-Inflammatory Activity In Vitro and In Vivo
por: Zhou, Kailu, et al.
Publicado: (2023)

Gypenoside XVII protects against myocardial ischemia and reperfusion injury by inhibiting ER stress–induced mitochondrial injury
por: Yu, Yingli, et al.
Publicado: (2021)

Co-administration of berberine/gypenosides/bifendate ameliorates metabolic disturbance but not memory impairment in type 2 diabetic mice
por: Zhang, Meng, et al.
Publicado: (2021)

Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities
por: ZHAO, JIE, et al.
Publicado: (2014)

Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
por: Zhao, Ting Ting, et al.
Publicado: (2017)

Effects of Plant Elicitors on Growth and Gypenosides Biosynthesis in Cell Culture of Giao co lam (Gynostemma pentaphyllum)
por: Quang, Hoang Tan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gtfsli5j44quau2b4vmuu24693